Sona Haku

528 total citations
25 papers, 366 citations indexed

About

Sona Haku is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Sona Haku has authored 25 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in Sona Haku's work include Renin-Angiotensin System Studies (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Hormonal Regulation and Hypertension (6 papers). Sona Haku is often cited by papers focused on Renin-Angiotensin System Studies (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Hormonal Regulation and Hypertension (6 papers). Sona Haku collaborates with scholars based in Japan, Singapore and United States. Sona Haku's co-authors include Kouichi Tamura, Hiromichi Wakui, Kengo Azushima, Kazushi Uneda, Satoshi Umemura, Akio Yamashita, Ryu Kobayashi, Yoshiyuki Toya, Masato Ohsawa and Miyuki Matsuda and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Sona Haku

24 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sona Haku Japan 13 182 101 97 66 59 25 366
Yuko Tsurumi‐Ikeya Japan 15 307 1.7× 140 1.4× 97 1.0× 74 1.1× 59 1.0× 19 473
Allison B. Lehtinen United States 13 126 0.7× 106 1.0× 158 1.6× 63 1.0× 55 0.9× 16 508
Beata Marie Redublo Quinto Brazil 12 106 0.6× 78 0.8× 84 0.9× 55 0.8× 45 0.8× 33 358
Atsu-ichiro Shigenaga Japan 12 294 1.6× 131 1.3× 88 0.9× 42 0.6× 66 1.1× 16 388
Kumiko Kaifu Japan 12 118 0.6× 194 1.9× 88 0.9× 86 1.3× 71 1.2× 15 426
Kazue Ishikawa Japan 11 152 0.8× 153 1.5× 127 1.3× 112 1.7× 46 0.8× 19 453
Miodrag Janić Slovenia 14 315 1.7× 164 1.6× 93 1.0× 135 2.0× 60 1.0× 47 575
Kumiko Moriwaki Japan 14 122 0.7× 133 1.3× 103 1.1× 113 1.7× 85 1.4× 24 470
Bruno Sevá Pessôa Netherlands 7 143 0.8× 104 1.0× 100 1.0× 38 0.6× 50 0.8× 8 322
Yuichiro Makita Japan 13 114 0.6× 109 1.1× 128 1.3× 73 1.1× 89 1.5× 22 505

Countries citing papers authored by Sona Haku

Since Specialization
Citations

This map shows the geographic impact of Sona Haku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sona Haku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sona Haku more than expected).

Fields of papers citing papers by Sona Haku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sona Haku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sona Haku. The network helps show where Sona Haku may publish in the future.

Co-authorship network of co-authors of Sona Haku

This figure shows the co-authorship network connecting the top 25 collaborators of Sona Haku. A scholar is included among the top collaborators of Sona Haku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sona Haku. Sona Haku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Azushima, Kengo, Kazushi Uneda, Hiromichi Wakui, et al.. (2019). Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice. Scientific Reports. 9(1). 6201–6201. 15 indexed citations
2.
Haku, Sona, Hiromichi Wakui, Kengo Azushima, et al.. (2018). Early Enhanced Leucine-Rich α-2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice. BioMed Research International. 2018. 1–9. 24 indexed citations
3.
Ohki, Kohji, Hiromichi Wakui, Kengo Azushima, et al.. (2018). Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue. Scientific Reports. 8(1). 2846–2846. 18 indexed citations
4.
Haruhara, Kotaro, Hiromichi Wakui, Kengo Azushima, et al.. (2018). Angiotensin receptor-binding molecule in leukocytes in association with the systemic and leukocyte inflammatory profile. Atherosclerosis. 269. 236–244. 7 indexed citations
5.
Kobayashi, Ryu, Hiromichi Wakui, Kengo Azushima, et al.. (2017). An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model. Kidney International. 91(5). 1115–1125. 29 indexed citations
6.
Azushima, Kengo, Hiromichi Wakui, Kazushi Uneda, et al.. (2017). Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease. Clinical and Experimental Hypertension. 39(7). 665–671. 4 indexed citations
7.
Azushima, Kengo, Kohji Ohki, Hiromichi Wakui, et al.. (2017). Adipocyte‐Specific Enhancement of Angiotensin II Type 1 Receptor‐Associated Protein Ameliorates Diet‐Induced Visceral Obesity and Insulin Resistance. Journal of the American Heart Association. 6(3). 36 indexed citations
8.
Ohki, Kohji, Hiromichi Wakui, Kengo Azushima, et al.. (2017). ATRAP Expression in Brown Adipose Tissue Does Not Influence the Development of Diet-Induced Metabolic Disorders in Mice. International Journal of Molecular Sciences. 18(3). 676–676. 10 indexed citations
9.
Kobayashi, Ryu, Kouichi Tamura, Hiromichi Wakui, et al.. (2016). Effect of single-pill irbesartan/amlodipine combination-based therapy on clinic and home blood pressure profiles in hypertension with chronic kidney diseases. Clinical and Experimental Hypertension. 38(8). 744–750. 4 indexed citations
10.
Ohsawa, Masato, Kouichi Tamura, Hiromichi Wakui, et al.. (2015). Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia. Lipids in Health and Disease. 14(1). 161–161. 8 indexed citations
11.
Tamura, Kouichi, Hiromichi Wakui, Kengo Azushima, et al.. (2015). Angiotensin II Type 1 Receptor Binding Molecule ATRAP as a Possible Modulator of Renal Sodium Handling and Blood Pressure in Pathophysiology. Current Medicinal Chemistry. 22(28). 3210–3216. 15 indexed citations
12.
Maeda, Akinobu, Kouichi Tamura, Hiromichi Wakui, et al.. (2014). Effects of Ang II Receptor Blocker Irbesartan on Adipose Tissue Function in Mice with Metabolic Disorders. International Journal of Medical Sciences. 11(6). 646–651. 11 indexed citations
13.
Matsuda, Miyuki, Kouichi Tamura, Hiromichi Wakui, et al.. (2013). Upstream Stimulatory Factors 1 and 2 Mediate the Transcription of Angiotensin II Binding and Inhibitory Protein. Journal of Biological Chemistry. 288(26). 19238–19249. 14 indexed citations
14.
Tamura, Kouichi, Hiromichi Wakui, Akinobu Maeda, et al.. (2013). The Physiology and Pathophysiology of a Novel Angiotensin Receptor-binding Protein ATRAP/Agtrap. Current Pharmaceutical Design. 19(17). 3043–3048. 27 indexed citations
15.
Maeda, Akinobu, Kouichi Tamura, Tomohiko Kanaoka, et al.. (2012). Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure Lowering: Amlodipine and Candesartan Trial in Yokohama (ACTY). Clinical and Experimental Hypertension. 34(4). 249–257. 5 indexed citations
16.
Kanaoka, Tomohiko, Kouichi Tamura, Masato Ohsawa, et al.. (2012). Relationship of Ambulatory Blood Pressure and the Heart Rate Profile with Renal Function Parameters in Hypertensive Patients with Chronic Kidney Disease. Clinical and Experimental Hypertension. 34(4). 264–269. 10 indexed citations
17.
Tamura, Kouichi, Yuko Tsurumi‐Ikeya, Hiromichi Wakui, et al.. (2012). Therapeutic Potential of Low‐Density Lipoprotein Apheresis in the Management of Peripheral Artery Disease in Patients With Chronic Kidney Disease. Therapeutic Apheresis and Dialysis. 17(2). 185–192. 26 indexed citations
18.
Azushima, Kengo, Kouichi Tamura, Hiromichi Wakui, et al.. (2012). Aliskiren Induced Remarkable Hypertriglyceridemia. Internal Medicine. 51(24). 3387–3389.
19.
Dejima, Toru, Kouichi Tamura, Hiromichi Wakui, et al.. (2011). Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats. Journal of Hypertension. 29(10). 1919–1929. 17 indexed citations
20.
Tamura, Kouichi, Tomohiko Kanaoka, Masato Ohsawa, et al.. (2011). Emerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney disease.. PubMed. 1(3). 236–43. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026